Changing the diagnosis criteria of type 2 diabetes in pregnancy: do the ends justify the means?
Diabetes in pregnancy is a chronic disease that demands pharmacological therapy, time consuming, with frequent fetal testing and adherence to diet protocol. Given the consensus that glucose control is the key to maximizing outcome, how can the complication rate in the GDM and type 2 diabetes reveal a 3-5 fold rate of perinatal complication compared to the normal population? This review will address the scope of the problem reinforcing the need to address several issues. Should the diagnostic criteria for type 2 diabetes be altered or redefined, at least in pregnancy due to similarities that exist between GDM impaired glucose tolerance and type 2 diabetes.
Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, 1000 Tenth Avenue, Suite 10C, New York, NY 10019, USA. odlanger@chpnet.org
Oded
O
Langer
D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D016640:Diabetes, Gestational / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D005260:Female; D018149:Glucose Intolerance / Q000150:complications / Q000175:diagnosis; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008962:Models, Theoretical; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D012307:Risk Factors